LAVAL, Québec--(BUSINESS WIRE)--Altasciences is proud to support Alzamend Neuro, Inc. (Alzamend) in advancing a novel treatment for dementia related to Alzheimer’s disease (Alzheimer’s). In addition ...

Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category. This press ...

LAVAL, Québec--(BUSINESS WIRE)--Altasciences is proud to announce that CEO Chris Perkin has been recognized as a 2019 Red Jacket honoree. The Red Jacket Award was introduced by PharmaVOICE in 2014 to ...

LAVAL, Québec, August 21, 2025--(BUSINESS WIRE)--Altasciences is pleased to have been chosen by Steel Therapeutics, Inc. ("Steel"), to initiate a pivotal toxicology study for Fizurex™, a novel topical ...

Laval, Quebec-based Altasciences has acquired WCCT Global, a Cypress, California-based early-stage clinical research organization. No financial terms were disclosed. Altasciences, a CRO specializing ...

Altasciences, just weeks after it was bought out by Novo Holdings, is remaining bullish on its buyout as it grabs Calvert Laboratories. The preclinical CRO, based on the East Coast, will “complement ...

LAVAL, Quebec — Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington. This transaction will support Altasciences’ goal of being a mid ...

LAVAL, Québec--(BUSINESS WIRE)--#Biotech--Altasciences hired two expert advisors to support its strategic growth in Europe, while its preclinical team continues to expand with the addition of two key ...

Altasciences, a forward-thinking CRO/CDMO supporting all crucial steps in early-stage drug development, from lead candidate selection to clinical proof of concept, announced today that they have ...

FARGO — Altasciences, which performs clinical and preclinical research studies in the U.S. and Canada for biopharmaceutical firms, is closing up operations at its south Fargo office due to a slowdown ...

LAVAL, Quebec--(BUSINESS WIRE)--#CDMO--Altasciences, a fully integrated early phase CRO/CDMO has started the expansion of their CDMO facility in Philadelphia, PA. The additional 35,000-square-foot ...

LAVAL, Québec, March 28, 2025--(BUSINESS WIRE)--Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule ...